Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients [Phase 4]
A Phase 4 clinical trial evaluated the immunogenicity of a Hepatitis A vaccine in patients with inflammatory bowel disease, including Crohn'…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care [Phase 2]
A Phase 2 trial evaluated telemedicine-based outpatient care for inflammatory bowel disease, including ulcerative colitis and Crohn's diseas…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Effect of FAn-7 in UC Activity [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating the effect of FAn-7 on ulcerative colitis activity; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis [Phase 3]
Phase 3 study comparing once-daily vs conventional dosing of Asacol (mesalamine) for maintaining quiescent ulcerative colitis; the trial has…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR [Phase 3]
Phase 3 trial FER-IBD-COR evaluating Ferinject (ferric carboxymaltose) for correcting iron-deficiency anemia in inflammatory bowel disease h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis [Phase 4]
Phase 4 trial assessing whether infliximab induces histologic and endoscopic remission in moderate to severe ulcerative colitis; study statu…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC) [Phase 4]
Phase 4 clinical trial evaluating leukocytapheresis for ulcerative colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]
This update reports results from a Phase 3 study of adalimumab in Japanese patients with moderately to severely active ulcerative colitis, w…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis [Phase 3]
An update on a Phase 3 trial assessing the efficacy and safety of adalimumab for inducing clinical response in ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Thalidomide in Pediatric Inflammatory Bowel Diseases. [Phase 3]
Phase 3 pediatric trial of thalidomide for inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis [Phase 3]
Phase 3 clinical trial update for Home Telemanagement (UC HAT) in ulcerative colitis has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Open-Label Adalimumab for Ulcerative Colitis Patients [Phase 1]
An open-label Phase 1 trial evaluated adalimumab in patients with ulcerative colitis. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis [Phase 1]
Phase 1 trial assessing safety and tolerability of a single dose of ASP3291 in adults with Ulcerative Colitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial comparing budesonide capsules to mesalazine granules in active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial comparing once-daily versus three-times-daily dosing of mesalazine granules for prevention of Ulcerative Colitis recurrence ha…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Phase 3]
A Phase 3 trial in children and adolescents evaluating maintenance therapy with Asacol (mesalamine) for Ulcerative Colitis was terminated, w…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis [Phase 3]
Phase 3 trial completed evaluating the safety and effectiveness of a new medication for active Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis [Phase 3]
The update reports the completion of a Phase 3 trial (FACTS II) evaluating a new medication for active Ulcerative Colitis. The study lists O…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) [Phase 2]
The Phase 2 study of visilizumab for intravenous steroid-refractory ulcerative colitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [Phase 4]
Phase 4 clinical trial evaluating changes in apoptosis regulators after stopping 5-aminosalicylic acid treatment in inactive ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™) [Phase 2]
Phase 2 trial of CyCol, an oral colonic-release ciclosporin, for mild to moderate ulcerative colitis has been completed.
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Phase 3]
A Phase 3 pediatric trial assessing the safety and efficacy of Asacol (mesalamine) given every 12 hours in children and adolescents with act…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis [NA]
This document reports the completion of the pediatric ADAPT Adacolumn trial for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]
A Phase 2 safety and efficacy study of bovine intestinal alkaline phosphatase in patients with moderate to severe ulcerative colitis has com…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 clinical study of HuZAF, a humanized anti-Interferon-γ monoclonal antibody, for moderate-to-severe Crohn's disease has completed.